'Nightmare' antibiotic-resistant bacteria detected in 27 states

More than 200 rare antibiotic-resistant genes were found in bacteria tested in 2017


A Centers for Disease Control and Prevention (CDC)  Vital Signs report found more than 200 rare antibiotic-resistant genes in "nightmare" bacteria tested in 2017, according to an article on the CNN website.

The report focused on the new and highly resistant germs found in 27 states, but a variety of resistant germs can be found in every state.

While public health officials concentrate on containment protocols, each of us can help limit antibiotic resistance by keeping our hands clean and disinfecting cuts, the CDC recommended. 

Because patients transfer from hospitals and nursing homes, germs can spread across the nation.

Read the article.

 

 



April 6, 2018


Topic Area: Infection Control


Recent Posts

Joint Commission Standards: What Updates Matter Most?

The latest revisions are streamlined and aligned with the Centers for Medicare and Medicaid Services, but the facility manager’s learning curve is steep.


Swinerton Completes Construction at Atlanta's Grady Hospital

Projects mark Swinerton’s first partnership with Georgia’s largest hospital.


NY Governor Hochul Announces $300M in Funds for IT and Cybersecurity

Awardees include hospitals in every region of the state.


Healthcare Is the New Retail

How site selection strategies are shaping the future of medical real estate.


Bridgeway Behavioral Health Services Launches Campaign to Renovate Health Center

The $2 million capital campaign aims to renovate and expand the outpatient behavioral health center in Elizabeth, New Jersey.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.